Funder: National Institutes of Health
Due Dates: October 3, 2024 | April 3, 2025 | October 3, 2025 | April 3, 2026
Funding Amounts: No direct funds; award is access to NICHD’s Chemical Synthesis and Optimization Facility for up to 12 months.
Summary: Provides access to preclinical chemical screening and optimization services to advance non-hormonal contraceptive and reproductive health product development.
Key Information: No clinical trials allowed; resource access only (X01 mechanism); applications must not overlap with existing PHS-funded efforts.